Volume 3

Happy Wednesday!

Over the past week, healthcare news has been dizzyingly fast and consequential. As always, I’ve highlighted the Top 10 things you need to know that could affect your team, patients, your business, and even your health.

In this week’s issue I’ve included information on: COVID and the return to normalcy, a new emerging global threat- Monkeypox, continued supply chain disruptions, and digital health trends. For deeper dives, click on the hyperlinks in summaries! Also, don’t forget to hit me up on social media at LinkedIn or Twitter!

1. The Federal Declaration of the Public Health Emergency (PHE) Continues

As COVID cases continue to increase with a new variant, the Biden administration has declared the continuation of the COVID-19 public health emergency. This allows people to acquire vaccines, COVID-19 testing, and treatment for free along with expanded health insurance coverage to more than 11 million Americans and access to telehealth services. With the PHE extension, the declaration will continue at least into the fall of ’22, giving states and the federal government the time and resources needed to prepare for further COVID surges.

So What’s The Big Deal? Allowing the PHE to lapse could have significant economic impacts on the out-of-pocket expenses for patients. As a result, revenues for hospitals and other healthcare entities could decline. Additionally, new technologies and services supported by telehealth could be forced into a pre-COVID regulatory environment, limiting further innovation and potentially limit present use.

Follow me on social:

Thanks for reading the Top 10 Big Deals in Healthcare and be sure to share with your network: